Latest Story

Latest Posts

  • Pharma
  • June 9, 2025
  • 102 views
Drug smuggling racket busted inside Ropar jail; ASI, head constable, among others arrested

Ropar police today busted a drug smuggling racket inside Ropar jail. SSP Ropar, Gulneet Singh Khurana, said that a gang involved in smuggling drugs and other prohibited items into Ropar…

  • Pharma
  • June 9, 2025
  • 94 views
Nepal ex-PM under fire for alleged corruption over Patanjali-linked land deal, fined $1 million

Authorities in Nepal have charged former Prime Minister Madhav Kumar Nepal with corruption and demanded a million-dollar fine over the purchase of land by a firm owned by Indian yoga…

  • Pharma
  • June 9, 2025
  • 104 views
NCB seizes Rs 9.2 crore assets of ‘prime accused’ in transnational drugs trafficking case from Noida

The Narcotics Control Bureau (NCB) on Sunday said it has attached a flat and a factory premises worth ₹9.20 crore in Uttar Pradesh’s Noida of a “prime” accused involved in…

  • Pharma
  • June 6, 2025
  • 386 views
Wockhardt’s novel antibiotic Zaynich eyes $9 billion global market

Mumbai-based pharma major Wockhardt, which is all set to launch its new class of antibiotic Zaynich targeted at treating complicated gram-negative infections in India this year, estimates that the drug…

  • Pharma
  • June 6, 2025
  • 250 views
Fake cosmetics racket busted in Bhubaneswar’s Unit-1 Market

In a joint crackdown, Odisha’s Drugs Control administration and Crime Branch Special Task Force (STF) raided Unit-1 Market in Bhubaneswar on Thursday, seizing duplicate cosmetic products sold under top brand…

  • Pharma
  • June 6, 2025
  • 272 views
Illegally stocked drugs worth Rs 5.21 lakh seized

HYDERABAD:  The Drugs Control Administration (DCA) raided the residence of a habitual offender in Moosarambagh, Malakpet, and seized spurious drugs worth Rs 5.21 lakh. The accused, Puvvada Lakshmana, is a…

  • Pharma
  • June 5, 2025
  • 239 views
Patanjali and AIIMS Bhopal partner to develop holistic treatment solutions

AIIMS Bhopal has taken a historic step toward integrating Indian systems of medicine with modern healthcare through a Memorandum of Understanding (MoU) signed with the Patanjali Research Foundation Trust. This…

  • Pharma
  • June 5, 2025
  • 276 views
NPPA fixes retail prices for 41 drug combinations, including empagliflozin

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 41 drug combinations, including 18 variants of the off-patent diabetes drug empagliflozin, originally developed by German pharmaceutical company…

  • Pharma
  • June 4, 2025
  • 467 views
Drug Inspector Dismissed After Rs 4 Crore Cash Found in Sacks; Linked to Illegal Sale of Pharmacist Degrees

Patna: A drug inspector in Bihar has been dismissed from service following the discovery of Rs 4 crore in cash during a raid in 2022, along with evidence of extensive corruption,…

  • Pharma
  • June 4, 2025
  • 337 views
Delhi Crime branch cracks down on fake cancer drug sellers, arrest six individuals

New Delhi :  The Crime Branch of Delhi Police has busted a racket selling spurious cancer medicines and injections, arresting six individuals and seizing several high-value spurious cancer drugs on…

  • Pharma
  • June 4, 2025
  • 128 views
‘Made in India’ Surgical Robot SSI Mantra’s Hallowed NASDAQ Moment in New York

New Delhi: It was a hallowed moment of pride for surgical robot SSI Mantra, its architect and robotic surgery wizard Dr Sudheer Srivastava, entire Indian Medtech Industry and ‘Make in…

  • Pharma
  • June 4, 2025
  • 288 views
Zydus to acquire 2 biologics manufacturing units in U.S. from Agenus for $125 million

Zydus Lifesciences plans to acquire Nasdaq-listed clinical-stage immuno-oncology firm Agenus’s two biologics manufacturing facilities in California, U.S. for $125 million to enter the global biologics contract development and manufacturing organization…

  • Pharma
  • June 3, 2025
  • 230 views
Ananda Pharma advances CBD drug with Phase 1 study listing

LONDON –  Ananda Pharma PLC (AQSE:ANA), a UK-based biopharmaceutical company, has announced the publication of its Phase 1 pharmacokinetic study on the clinical trial registry clinicaltrials.gov, with the reference number…

With Advent of Level Playing Field, Domestic MedTech Industry exclaims ‘Eureka!’

AiMed showers unqualified praise on Government for jettisoning foreign favoritism New Delhi: Rajiv Nath, one of the greatest champions of Make in India and no nonsense leader of domestic medical…

Govt supports indigenous manufacturing of complex pharma excipients by Nitika Pharmaceutical Specialties

For commercial-scale production of 14 complex excipients The Technology Development Board (TDB), Department of Science and Technology (DST), Government of India has extended financial support to Nitika Pharmaceutical Specialties Private…

  • Pharma
  • June 3, 2025
  • 298 views
Medical representatives barred from govt hospitals to stop pharma influence

Medical representatives will no longer be permitted to meet doctors directly within central government hospitals, following a directive from the Centre aimed at putting an end to the nexus between…

  • Pharma
  • May 31, 2025
  • 394 views
Generic drugs can bring hope for SMA patients’

Dr Ann Agnes Mathew, a consultant paediatric neurologist and neuromuscular specialist based in Bengaluru, treats nearly 600 SMA patients from across India. In an interview with DH’s Udbhavi Balakrishna, she…

  • Pharma
  • May 31, 2025
  • 381 views
47% of pharma MOUs from VGGS 2024 commissioned

Gandhinagar:  The state govt said that 47% of MoUs signed in the pharmaceutical sector in the Vibrant Gujarat Global Summit (VGGS) 2024 have been commissioned. It said on Friday that…

  • Pharma
  • May 30, 2025
  • 338 views
I-Sec downgrades Aurobindo Pharma to Add, target price Rs 1,330

ICICI Securities has downgraded Aurobindo Pharma to Add (from Buy earlier) with a revised target price of Rs 1,330 (earlier Rs 1,445). The current market price of Aurobindo Pharma Ltd.…

  • Pharma
  • May 30, 2025
  • 140 views
AstraZeneca gets CDSCO nod for lung cancer drug

New Delhi:  AstraZeneca India Pharma on Thursday said it has received approval from the government authority for the import, sale, and distribution of a medication used in treating non-small cell…